Ergoteles LLC Abbott Laboratories Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $306,875 - $341,923	3,045 New	3,045 $331,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $3.54 Million - $4.15 Million	-37,220 Reduced 94.49%	2,170 $238,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $7.62 Million - $8.82 Million	-78,762 Reduced 66.66%	39,390 $3.81 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $12.1 Million - $14.6 Million	118,152 New	118,152 $12.8 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $14.8 Million - $17.5 Million	-140,198 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $3.18 Million - $3.75 Million	29,218 Added 26.33%	140,198 $16.8 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $11.7 Million - $12.7 Million	110,980 New	110,980 $12.2 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.